India has banned all exports of hydroxychloroquine - an anti- malaria drug that is being used in the treatment of Covid-19.

This implies that the exceptions (export obligation and humanitarian grounds) mentioned in the previous order have come to an end.

The Directorate-General of Foreign Trade (DGFT) had prohibited the export of the drug on 25th March, 2020. But it left the option of export open to fulfil “export obligation” and on “humanitarian grounds”.

The Directorate General of Foreign Trade (DGFT) organisation is an attached office of the Ministry of Commerce and Industry. This Directorate, with headquarters at New Delhi, is responsible for formulating and implementing the Foreign Trade Policy with the main objective of promoting India’s exports.